纸莎草的化学成分研究(三)

化合物7无色晶体,纸莎分子式为C29H50O,草的成分分子量414,化学25D=-27.1(c0.01,研究CHCl3)。纸莎1HNMR(400MHz,草的成分CDCl3)δ:5.34(1H,化学s,研究H-6),纸莎3.51(1H,草的成分m,化学H-3),研究2.28~1.09(30H,纸莎m),草的成分0.99(3H,化学s,H-19),0.92(3H,d,J=6.5Hz,H-21),0.85(3H,d,J=7.2Hz,H-29),0.84(3H,d,J=6.5Hz,H-26),0.81(3H,d,J=8.6Hz,H-27),0.68(3H,s,H-18);13CNMR(100MHz,CDCl3)δ:140.9(C-5),121.7(C-6),77.8(C-3),56.8(C-14),56.1(C-17),50.2(C-9),45.9(C-4),42.4(C-13),39.8(C-12),37.3(C-24),36.5(C-1),36.2(C-10),34.0(C-22),31.9(C-8、C-20),31.7(C-7),29.7(C-2),29.2(C-16),28.3(C-11),26.1(C-15),24.3(C-23),23.1(C-28),21.1(C-27),19.8(C-19),19.4(C-21),19.1(C-25),18.8(C-29),12.0(C-26),11.9(C-16)。以上数据与文献报道数据基本一致,故鉴定化合物7为β-谷甾醇。
化合物8白色晶体,分子式为C29H46O2,分子量426,25D=-38.1(c0.01,CHCl3)。1HNMR(400MHz,CDCl3)δ:6.18(1H,s,H-4),2.68(1H,dd,J=16.0,4.0Hz,H-7a),2.48~2.59(2H,m,H-7b,H-2b),2.13~2.17(1H,m,H-2a),1.16(3H,s,H-19),0.95(3H,d,J=6.5Hz,H-21),0.84(3H,t,J=2.8Hz,H-29),0.82(3H,d,J=2.1Hz,H-26),0.81(3H,d,J=2.8Hz,H-27),0.71(3H,s,H-18);13CNMR(100MHz,CDCl3)δ:202.4(C-6),199.6(C-3),161.1(C-5),125.5(C-4),56.5(C-9),55.8(C-17),51.0(C-14),46.8(C-13),45.8(C-7),42.5(C-12),39.8(C-10),39.1(C-24),36.0(C-22),35.5(C-1),34.2(C-20),34.0(C-8),33.8(C-2),29.1(C-16),28.0(C-25),26.0(C-28),24.0(C-15),23.0(C-23),20.9(C-26),19.8(C-11),19.0(C-27),18.7(C-21),17.5(C-19),12.0(C-29),11.9(C-18)。以上数据与文献报道数据基本一致,故鉴定化合物8为(24R)-24-乙基胆甾烷-4-烯-3,6-二酮。
化合物9白色晶体,分子式为C29H46O,分子量410,25D=+40.4(c0.13,CHCl3)。1HNMR(400MHz,CDCl3)δ:5.72(1H,s,H-4),5.17(1H,dd,J=16.0,9.0Hz,H-22),5.03(1H,dd,J=16.0,9.0Hz,H-23),1.17(3H,s,H-19),1.02(3H,d,J=7.0Hz,H-21),0.84(3H,d,J=6.0Hz,H-27),0.81(3H,m,H-29),0.80(3H,d,J=6.0Hz,H-26),0.72(3H,s,H-18);13CNMR(100MHz,CDCl3)δ:199.6(C-3),171.7(C-5),138.2(C-22),129.4(C-23),123.7(C-4),55.9(C-17),53.8(C-9),53.5(C-14),51.2(C-24),42.3(C-13),40.5(C-20),39.6(C-12),38.6(C-10),35.7(C-1),35.6(C-8),34.0(C-2),33.8(C-6),33.0(C-7),32.0(C-25),29.0(C-16),25.4(C-28),24.2(C-15),23.0(C-21),21.0(C-27),19.8(C-11),19.0(C-26),17.4(C-19),12.3(C-29),11.9(C-18)。以上数据与文献报道数据基本一致,故鉴定化合物9为豆甾-4,22-二烯-3-酮。
化合物10白色固体,分子式为C29H50O3,分子量446,25D=+17.4(c0.13,CH3OH)。1HNMR(400MHz,CD3OD)δ:4.05(1H,s,H-5b),3.51(1H,m,H-3),0.94(3H,d,J=6.0Hz,H-21),0.85(3H,t,J=6.0Hz,H-29),0.84(3H,d,J=6.0Hz,H-26),0.81(3H,t,J=6.0Hz,H-27),0.80(3H,d,J=6.0Hz,H-26),0.78(3H,s,H-19),0.68(3H,s,H-18);13CNMR(100MHz,CD3OD)δ:217.5(C-6),81.9(C-5),67.5(C-3),58.8(C-14),56.7(C-17),44.8(C-24),43.6(C-10),41.5(C-13),40.5(C-9),40.4(C-7),39.1(C-12),35.3(C-8),34.7(C-4),30.2(C-20),29.8(C-22),28.4(C-25),27.8(C-16),27.2(C-2),27.0(C-23),26.5(C-1),25.4(C-15),23.9(C-28),22.3(C-11),21.5(C-27),20.7(C-26),20.2(C-19、C-21),12.1(C-18、C-29)。以上数据与文献报道数据基本一致,故鉴定化合物10为(24R)-24-乙基-5α-胆甾烷-3β,5-二醇-6-酮。
化合物11白色固体,分子式为C29H48O,分子量412,20D=-51.1(c0.12,CHCl3)。1HNMR(400MHz,CDCl3)δ:5.37(1H,s,H-6),5.18(1H,dd,J=15.0,8.7Hz,H-22),5.01(1H,dd,J=15.0,8.7Hz,H-23),3.51(1H,m,H-3),2.28~1.22(26H,m),1.04(3H,d,J=6.5Hz,H-21),0.99(3H,s,H-19),0.89(3H,t,J=7.2Hz,H-29),0.82(3H,d,J=6.5Hz,H-26),0.81(3H,d,J=8.6Hz,H-27),0.70(3H,s,H-18);13CNMR(100MHz,CDCl3)δ:140.8(C-5),138.3(C-22),129.3(C-23),121.7(C-6),71.8(C-3),56.8(C-17),56.1(C-14),50.2(C-9),45.9(C-24),42.3(C-13),39.8(C-12),37.3(C-4),36.5(C-1),34.0(C-12),31.9(C-7),31.7(C-8),29.2(C-24),28.2(C-2),26.1(C-16),24.3(C-15),23.1(C-27),21.1(C-11),19.8(C-28),19.4(C-29),19.1(C-26),18.8(C-21),12.0(C-19),11.9(C-18)。以上数据与文献报道数据基本一致,故鉴定化合物11为豆甾醇。
化合物12白色固体,分子式为C29H48O2,分子量428,25D=+72.2(c0.17,CHCl3)。1HNMR(400MHz,CDCl3)δ:5.82(1H,s,H-4),4.34(1H,m,H-5),1.39(3H,s,H-19),0.93(3H,d,J=6.5Hz,H-21),0.84(3H,t,J=7.0Hz,H-29),0.83(3H,d,J=7.0Hz,H-26),0.81(3H,d,J=6.5Hz,H-27),0.73(3H,s,H-18);13CNMR(100MHz,CDCl3)δ:200.5(C-3),168.6(C-5),126.3(C-4),73.2(C-6),56.1(C-17),55.9(C-14),53.6(C-9),45.8(C-24),42.5(C-13),39.6(C-12),38.6(C-7),38.0(C-10),37.1(C-1),36.1(C-20),34.3(C-2),33.9(C-22),29.7(C-8),29.2(C-25),28.2(C-16),26.1(C-23),24.2(C-15),23.1(C-28),21.0(C-11),19.8(C-26),19.5(C-19),19.0(C-21),18.7(C-27),12.0(C-29),11.9(C-18)。以上数据与文献报道数据基本一致,故鉴定化合物12为豆甾-4-烯-6β-醇-3-酮。
化合物13白色固体,分子式为C29H48O2,分子量428,25D=+27.2(c0.19,CHCl3)。1HNMR(400MHz,CDCl3)δ:0.99(3H,s,H-19),0.93(3H,d,J=5.7Hz,H-21),0.85(3H,d,J=6.5Hz,H-26),0.84(3H,m,H-29),0.83(3H,d,J=6.6Hz,H-27),0.68(3H,s,H-18);13CNMR(100MHz,CDCl3)δ:211.5(C-6),209.2(C-3),57.5(C-5),56.6(C-17),56.0(C-14),53.5(C-9),46.6(C-7),45.8(C-24),43.0(C-13),41.3(C-10),39.4(C-2),38.1(C-1),38.0(C-12),37.4(C-8),37.0(C-4),36.0(C-20),33.8(C-22),29.2(C-25),28.0(C-16),26.1(C-23),24.0(C-15),23.1(C-28),21.7(C-11),19.8(C-26),19.0(C-27),18.7(C-21),12.2(C-18),12.0(C-29),11.9(C-19)。以上数据与文献报道数据基本一致,故鉴定化合物13为豆甾-3,6-二酮。
声明:本文所用图片、文字来源《天然产物研究与开发》,版权归原作者所有。如涉及作品内容、版权等问题,请与本网联系删除。
相关链接:晶体,分子,化合物
相关文章
- 发布者:小宁 阅读次数:592发布时间:2022/3/30 15:39:16 在饮品的深度调整与消费升级的驱动下,饮品领域充斥着革新,同时市场规模也不断扩大,参与品牌也逐渐增2025-08-10
- 上週,美國最大的虛擬貨幣交易平台Coinbase正式上市,虛擬貨幣市場一片狂歡。不料還不到一週,以比特幣為首的虛擬貨幣就在周末重挫逾10%。現在看來,短期內虛擬貨幣市場仍會持續震盪。您的閱讀篇數已達上2025-08-10
厉害了!英国研制出智能玻璃,可自由切换透明玻璃和磨砂玻璃状态,行业资讯
玻璃,我们生活的角落无处不在的伟大发明,给人类带来了非常大的便利,它应用在很多东西上,比如高楼大厦,比如汽车,比如窗户,门等等,都有它的身影,近日,英国的ESG公司发明了一种新型的玻璃,一起来看看吧!2025-08-10南玻A:拟为吴江两家全资子公司合计提供不超2亿元连带责任担保,企业新闻
南玻A(000012)晚间公告称,为保证公司正常经营,提高资金利用率及综合竞争力,公司拟为全资子公司吴江南玻玻璃有限公司(简称“吴江南玻”)、吴江南玻华东工程玻璃有限公司(简称“华东工程玻璃”)合计不2025-08-10- 瞄准建链强链补链目标,精挑细选招好商南安20个项目苗子 计划引资118.9亿元本报讯 记者王宇静 通讯员陈鑫炜 吴泉瑜)泉州市近日启动2020年泉州市产业链招商季行动,各地纷纷响应。为进一步引入&ld2025-08-10
- 由台企瀚元康养集团发起成立的两岸生物医疗融合发展中心近日在福州正式启用。据介绍,该中心设置生物医药科研创新空间、交流互动空间、办公协同空间,集展示、孵化、培训等功能于一体,将为生物科技、医疗医药、养生2025-08-10
最新评论